Savvy investors should be keeping a close eye on some key developments that have taken place within the past year relating to Alzheimer’s disease, medical cannabis, and India Globalization Capital (NYSE MKT: IGC). These developments include exciting, if preliminary, results relating to the effect of THC on amyloid-beta plaques—which are the plaques on neurons associated with Alzheimer’s disease—and a critical link between the related technology and IGC.
“This information was summarized in an article first published on Benzinga (http://nnw.fm/6SSZi) and recently adapted for HIGH TIMES (http://nnw.fm/7AZcm), titled ‘Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work.’
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
India Globalization Capital, Inc. (NYSE MKT: IGC) May Hold Blockbuster Position for Alzheimer’s Treatment
